Fig. 4From: A global real-world assessment of the impact on health-related quality of life and work productivity of migraine in patients with insufficient versus good response to triptan medicationPatient-reported work productivity and activity impairment according to patient response to triptan medication. *p < 0.05; †p < 0.001 for TIRs versus TRs using multivariable general linear model controlling for age, sex, migraine headache day frequency, comorbidities, duration of illness, preventive medication use, and migraine with or without aura. Note: Higher WPAI score indicates greater impairment. LS = least squares; WPAI=Work Productivity and Activity ImpairmentBack to article page